Dr Setefilla Luengo

Agency:

AETS

Job Title:

Head of Area

Organisation:

Agencia de Evaluacion de Tecnologias Sanitarias

Tel:

(+34) 91-822 2078

Fax:

(+34) 91-387 7841

Email:

sluengo@isciii.es

Website:

http://sintesis.isciii.es/sintesis

Address:

Instituto de Salud Carlos III, Sinesio Delgado 4, 28029, Madrid, Spain

Agency Member Since:

26/5/1998

Additional Contacts:

Mar Polo

EAAS Name:

SINTESIS-new technologies

EAAS Host Organisation:

AETS

EAAS Status:

Permanent

EAAS Main Output Language:

Spanish

EAAS Description:

The development of SINTESIS - new technologies responds to the mandates regarding AETS functions, Royal Decree 375/2001, and the National Health System’s (SNS) Interterritorial Council plenary session agreement which defined the work to be developed by the Health Technology Assessment Working Group. The objective of SINTESIS - new technologies is to identify new and emerging technologies susceptible of being evaluated in the future, and recover information on these technologies and their possible impacts. The system intends to contribute to better decision making policies by the health personnel in charge, by providing useful and timely information regarding relevant new technologies for the public health system. The final output of the EAAS covers the potential for future impact, safety and efficacy/ clinical effectiveness of the technology. The output takes the form of a short 1-4 page report (technical card).

Main source of funding:

National health system - Department of Health or health services

Purpose of EAAS:

• To inform decisions on coverage or reimbursement of health services
• To inform decisions on captical or recurrent spending
• To inform decisions on undertaking primary research
• To inform decisions on undertaking secondary research (health technology assessments, systematic reviews)

Types of technologies covered by EAAS:

• Devices (including imaging equipment)
• Diagnostics (diagnostic and prognostic biomarkers)
• Interventional procedures (e.g. surgery)
• Programmes (e.g. screening and vaccination programmes)
• Health care settings (e.g. organisational changes, professional boundaries)

Main customers of EAAS:

• National Government Health Departments & Ministers
• Health services purchasers, commissioners or other decision makers
• Health care providers e.g. hospitals
• Health care professionals, medical advisors or clinical experts
• National research & development programme
• Insurance or re-imbursement organisations
• Consumers

Contents of Main Output from EAAS:

• Potential for significant health service impact
• Safety and efficacy
• Assessment of clinical effectiveness
• Assessment of cost effectiveness
• Other:
• Social, legal and ethical impact